The ARRIVE Trial
- PMID: 38032824
- DOI: 10.1097/GRF.0000000000000844
The ARRIVE Trial
Abstract
Timing of delivery such that maternal and perinatal outcomes are optimized is among the most important and commonplace decisions in obstetric care. Given the importance of this determination, it is somewhat surprising that there has been, until relatively recently, little in the way of high-quality evidence to guide obstetric clinicians in this decision. This chapter describes the evolution of studies examining the effects of labor induction and the importance of the ARRIVE trial in that context.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Practice bulletin no. 146: Management of late-term and postterm pregnancies. Obstet Gynecol. 2014;124:390–396.
-
- Yeast JD, Jones A, Poskin M. Induction of labor and the relationship to cesarean delivery: a review of 7001 consecutive inductions. Am J Obstet Gynecol. 1999;180:628–633.
-
- Seyb ST, Berka RJ, Socol ML, et al. Risk of cesarean delivery with elective induction of labor at term in nulliparous women. Obstet Gynecol. 1999;94:600–607.
-
- Dublin S, Lydon-Rochelle M, Kaplan RC, et al. Maternal and neonatal outcomes after induction of labor without an identified indication. Am J Obstet Gynecol. 2000;183:986–994.
-
- Johnson DP, Davis NR, Brown AJ. Risk of cesarean delivery after induction at term in nulliparous women with an unfavorable cervix. Am J Obstet Gynecol. 2003;188:1565–1569.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources